Key facts

General presentation

Latest aide memoire


This data might not be the latest available

Upcoming events

First interim dividend ex-dividend date

First interim dividend record date

Post H1 roadshow, Helsinki (IR)


Annual Reports

 


Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Henry Wheeler

Oncology

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

Craig Marks

Finance, fixed income

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

Tom Waldron

Other medicines

Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries


  • Shareholder information

    Please find relevant shareholder information and shareholder tools on this page


  • Shareholder FAQs

    Answers to frequently asked shareholder questions


  • Governance

    We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance